Drug Profile
Research programme: combretastatin A4 analogues - Charlesson
Alternative Names: CLT-006-001; SU168; SU178Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Charlesson
- Class
- Mechanism of Action Tubulin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Eye disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Eye-disorders in USA
- 03 Sep 2008 Preclinical trials in Eye disorders in USA (unspecified route)